Ignite Creation Date:
2024-05-06 @ 5:49 PM
Last Modification Date:
2024-10-26 @ 2:36 PM
Study NCT ID:
NCT05444920
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2022-06-30
Brief Title:
The Italian Transthyretin Amyloidosis Web-Network
Sponsor:
Fondazione IRCCS Policlinico San Matteo di Pavia
Organization:
Fondazione IRCCS Policlinico San Matteo di Pavia
Study Overview
Official Title:
The Italian Transthyretin Amyloidosis Web-Network ITA-WebNet
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ITA-WebNet
Brief Summary:
The study aims by generating a large registry of patients with ATTR amyloidosis including data at diagnosis and during follow up to describe the natural history of ATTR amyloidosis in a real-world setting and to define and validate prognostic models response criteria applicable at any point of the disease The registry will also be used for data sharing and to allow the possibility of a close collaboration amongst the amyloidosis experts of the ARTC and all the physicians around the Country involved in the diagnosis and management of systemic amyloidosis Thanks to the online registry the diagnostic facility of the ARTC will be made available to requesting physicians
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None